The goal of the partnership between Topcon and Pangaea is to “accelerate the application of Pangaea’s clinically validated AI ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

India faces a growing crisis as childhood obesity rates rise sharply, increasing risks of diabetes and vision problems. Is CBSE's sugar board initiative enough to protect children's health?

Telangiectatic capillaries may have potential clinical relevance for diagnosis and treatment of diabetic macular edema.

In India, a significant portion of adults grapple with both thyroid disorders and diabetes, often unaware of their ...

The secret to a successful cataract surgery in diabetics lies in making informed decisions. Instead of being influenced by ...

A study, published in Science Translational Medicine, revealed that diabetic mice in induced periods of low sugar were ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

An oral drug that improves vision in DME [diabetic macular edema]  would be a game changer because it would be more ...

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin American ...

The global sales of ophthalmic lasers are estimated to be worth USD 976.8 million in 2024 and are anticipated to reach a value of USD 1,561.0 million by 2034. Sales are projected to rise at a CAGR of ...